Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers

Ingeborg J.H. Vriens, Kristien Keymeulen, Marc B.I. Lobbes, Annelotte C.M. van Bommel, Grard A.P. Nieuwenhuijzen, Marjolein L. Smidt, Liesbeth J. Boersma, Thijs van Dalen, Carolien H. Smorenburg, Henk Struikmans, Sabine Siesling, Adri C. Voogd, Vivianne C.G. Tjan-Heijnen*, the National Breast Cancer Organization of the Netherlands – Breast Cancer Audit Scientific Committee (NBCA)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
4 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences